These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia. Pamuk GE, Turgut B, Demir M, Tezcan F, Vural O. Am J Hematol; 2006 Aug; 81(8):631-3. PubMed ID: 16906592 [Abstract] [Full Text] [Related]
23. Childhood refractory autoimmune haemolytic anaemia: is there a role for anti-CD20 therapy (rituximab)? McMahon C, Babu L, Hodgson A, Hayat A, Connell NO, Smith OP. Br J Haematol; 2002 May; 117(2):480-3. PubMed ID: 11972537 [No Abstract] [Full Text] [Related]
24. Rituximab therapy for childhood Evans syndrome. Bader-Meunier B, Aladjidi N, Bellmann F, Monpoux F, Nelken B, Robert A, Armari-Alla C, Picard C, Ledeist F, Munzer M, Yacouben K, Bertrand Y, Pariente A, Chaussé A, Perel Y, Leverger G. Haematologica; 2007 Dec; 92(12):1691-4. PubMed ID: 18055994 [Abstract] [Full Text] [Related]
25. Efficacy and safety of rituximab in adults' warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases. Bussone G, Ribeiro E, Dechartres A, Viallard JF, Bonnotte B, Fain O, Godeau B, Michel M. Am J Hematol; 2009 Mar; 84(3):153-7. PubMed ID: 19123460 [Abstract] [Full Text] [Related]
26. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus. Kumar S, Benseler SM, Kirby-Allen M, Silverman ED. Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962 [Abstract] [Full Text] [Related]
27. Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anaemia. De Lord C, Marsh JC, Smith JG, Singer CR, Gordon-Smith EC. Bone Marrow Transplant; 1996 Jul; 18(1):237-9. PubMed ID: 8832026 [Abstract] [Full Text] [Related]
28. A life-threatening paediatric case of acute autoimmune haemolytic anaemia (AIHA) successfully cured by plasma-exchange and combined immunosuppressive treatment. Lucchini G, Masera N, Foti G, Assali G, Perseghin P, Biagi E. Transfus Apher Sci; 2009 Apr; 40(2):115-8. PubMed ID: 19237316 [Abstract] [Full Text] [Related]
29. Successful induction and maintenance of long-term remission in a child with chronic relapsing autoimmune hemolytic anemia using rituximab. Gottardo NG, Baker DL, Willis FR. Pediatr Hematol Oncol; 2003 Apr; 20(7):557-61. PubMed ID: 12959862 [Abstract] [Full Text] [Related]
30. Rituximab for refractory childhood autoimmune hemolytic anemia. Motto DG, Williams JA, Boxer LA. Isr Med Assoc J; 2002 Nov; 4(11):1006-8. PubMed ID: 12489491 [Abstract] [Full Text] [Related]
31. Cost-effectiveness of rituximab in refractory cold agglutinin disease. Panwar U, Mathews C, Cullis JO. Int J Lab Hematol; 2008 Aug; 30(4):331-3. PubMed ID: 18665831 [Abstract] [Full Text] [Related]
32. Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up. Rückert A, Glimm H, Lübbert M, Grüllich C. Lupus; 2008 Aug; 17(8):757-60. PubMed ID: 18625656 [Abstract] [Full Text] [Related]
33. Autoimmune haemolytic anaemia: pattern of presentation and management outcome in a Nigerian population: a ten-year experience. Salawu L, Durosinmi MA. Afr J Med Med Sci; 2002 Jun; 31(2):97-100. PubMed ID: 12518900 [Abstract] [Full Text] [Related]
34. Successful treatment with rituximab of autoimmune haemolytic anaemia causing dialysis-dependent acute renal failure. Brown CE, Traynor JP, Sharp RA, Fox JG. Nephrol Dial Transplant; 2007 Sep; 22(9):2730-1. PubMed ID: 17575312 [No Abstract] [Full Text] [Related]
35. Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune haemolytic anaemia associated with idiopathic membranous nephropathy. Rossi P, Demoux AL, Granel B, Bagnères D, Bonin-Guillaume S, Frances Y. Rheumatology (Oxford); 2005 Mar; 44(3):403-5. PubMed ID: 15637040 [No Abstract] [Full Text] [Related]
36. Remission of severe, intractable autoimmune haemolytic anaemia following matched unrelated donor transplantation. Pratt G, Kinsey SE. Bone Marrow Transplant; 2001 Oct; 28(8):791-3. PubMed ID: 11781633 [Abstract] [Full Text] [Related]
37. Rituximab for refractory Evans syndrome and other immune-mediated hematologic diseases. Mantadakis E, Danilatou V, Stiakaki E, Kalmanti M. Am J Hematol; 2004 Nov; 77(3):303-10. PubMed ID: 15495242 [Abstract] [Full Text] [Related]
38. Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases. O'Brien TA, Eastlund T, Peters C, Neglia JP, Defor T, Ramsay NK, Scott Baker K. Br J Haematol; 2004 Oct; 127(1):67-75. PubMed ID: 15384979 [Abstract] [Full Text] [Related]
39. Treatment of childhood autoimmune haemolytic anaemia with rituximab. Quartier P, Brethon B, Philippet P, Landman-Parker J, Le Deist F, Fischer A. Lancet; 2001 Nov 03; 358(9292):1511-3. PubMed ID: 11705566 [Abstract] [Full Text] [Related]
40. Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab. Hongeng S, Tardtong P, Worapongpaiboon S, Ungkanont A, Jootar S. Bone Marrow Transplant; 2002 May 03; 29(10):871-2. PubMed ID: 12058238 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]